North Alabama Research Center (NARC) and a sister site called Medical-Affiliated Research Center of Huntsville gear up to conduct major COVID-19 vaccine clinical trials sponsored by the BioNTech and Pfizer partnership. The site operation and study is overseen by Tonya Pryor at the Athens and Huntsville-based research centers. These sites have partnered with Pfizer in the past, successfully, and hence were selected for this pivotal Phase 3 clinical trial investigating the safety and efficacy of mRNA-based BNT162.
U.S. Fed Gov. Makes Large BNT162 Purchase
This week, the companies announced that the U.S. government made an advanced purchase of 100 million doses for $1.95 billion if the vaccine, BNT162, in fact provides to be safe and efficacious and therefore ultimately approved by the U.S. Food and Drug Administration (FDA). Moreover, the U.S. federal government secured an option for up to 500 million more doses.
The Study in North Alabama
The next major clinical trial will involve 150 clinical research sites around the United States. The Phase 3 trial will come to North Alabama thanks to the sponsors selecting the two sites Ms. Tonya Pryor manages. As sites ac...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).